Jennifer L Beaumont (Jennifer Beaumont)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 20

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Journal of the International Neuropsychological Society : JINS

Northwestern University Feinberg School of Medicine

University of North Carolina at Chapel Hill (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Northwestern University Feinberg School of Medicine

United States

Statistical Analyst/ Programmer :: Medical Social Sciences

Education History

University of North Carolina at Chapel Hill

United States

MSC :: Biostatistics

Missouri State University

United States

BSC :: Mathematics and Biology

Publications

April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Lynne I Wagner, Janet A Tooze, Daniel L Hall, Beverly J Levine, Jennifer L Beaumont, Jennifer Duffecy, David E Victorson, William Gradishar, Joseph Leach, Thomas Saphner, Keren Sturtz, Mary Lou Smith, Frank J Penedo, David C Mohr, David Cella
Targeted eHealth Intervention to Reduce Breast Cancer Survivors' Fear of Recurrence: Results From the FoRtitude Randomized Trial. Journal of the National Cancer Institute 113 (11) (2021)
Jennifer L Beaumont, Elizabeth S Davis, Jeffrey R Curtis, David Cella, Huifeng Yun
Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis. The Journal of rheumatology 48 (8) (2021)
Larysa J Sanchez, Xavier Leleu, Jennifer L Beaumont, Hailin Yu, Stacie Hudgens, Maryana Simonova, Holger W Auner, Hang Quach, Sosana Delimpasi, Ivan Špička, Ludĕk Pour, Iryna Kriachok, Meletios- Athanasios Dimopoulos, Ganna Usenko, Roman Hájek, Reuben Benjamin, Dinesh Kumar Sinha, Christopher Venner, Thomas Illmer, Mamta Krishnan Garg, Don Ambrose Stevens, Sundar Jagannath, Moshe Levy, Larry D Anderson, Nizar Jacques Bahlis, Thierry Facon, Michele Cavo, Yi Chai, Xiwen Ma, Shijie Tang, Hoyee Leong, Jatin Shah, Sharon Shacham, Michael Kauffman, Paul Richardson, Sebastian Grosicki
Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone. American journal of hematology 96 (10) (2021)
Intan Purnajo, Jennifer L Beaumont, Martin Polinsky, Evo Alemao, Matthew J Everly
Trajectories of health-related quality of life among renal transplant patients associated with graft failure and symptom distress: Analysis of the BENEFIT and BENEFIT-EXT trials. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (6) (2020)
Jennifer Verbesey, Alvin G Thomas, Matt Ronin, Jennifer L Beaumont, Amy D Waterman, Dorry L Segev, Stuart M Flechner, Matthew Cooper
Early graft losses in paired kidney exchange: Experience from 10 years of the National Kidney Registry. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (5) (2020)
Matthew Cooper, David B Leeser, Stuart M Flechner, Jennifer L Beaumont, Amy D Waterman, Patrick W Shannon, Matthew Ronin, Garet Hil, Jeffrey L Veale
Ensuring the need is met: A 50-year simulation study of the National Kidney Registry's family voucher program. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (3) (2020)
Amy D Waterman, John Devin Peipert, Yujie Cui, Jennifer L Beaumont, Andrea Paiva, Amanda Faye Lipsey, Crystal S Anderson, Mark L Robbins
Your Path to Transplant: A randomized controlled trial of a tailored expert system intervention to increase knowledge, attitudes, and pursuit of kidney transplant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (3) (2020)
Kaitlin B Casaletto, Anya Umlauf, Maria Marquine, Jennifer L Beaumont, Daniel Mungas, Richard Gershon, Jerry Slotkin, Natacha Akshoomoff, Robert K Heaton
Demographically Corrected Normative Standards for the Spanish Language Version of the NIH Toolbox Cognition Battery. Journal of the International Neuropsychological Society : JINS 22 (3) (2016)
Kaitlin B Casaletto, Anya Umlauf, Jennifer L Beaumont, Richard Gershon, Jerry Slotkin, Natacha Akshoomoff, Robert K Heaton
Demographically Corrected Normative Standards for the English Version of the NIH Toolbox Cognition Battery. Journal of the International Neuropsychological Society : JINS 21 (5) (2015)

Jennifer L Beaumont.css-eqlu8i{font-size:small;padding-left:4px;} (Jennifer Beaumont)

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer L Beaumont (Jennifer Beaumont)